July Existing Home Sales

Sorry, I could not read the content fromt this page.View the original article h...

Read More

May Existing-Home Sales

Sorry, I could not read the content fromt this page.View the original article h...

Read More

Insurance For The Poor

View the original article h...

Read More

My Insurance Has Been Denied: Now What?

View the original article h...

Read More

Choose the Right Lender for You

View the original article h...

Read More

How to Ensure a Profitable Investment Portfolio

View the original article h...

Read More

September Employment Statistics

Sorry, I could not read the content fromt this page.View the original article h...

Read More

Finding the Best Term Life Insurance Companies

View the original article h...

Read More

The Reality on PPI Insurance Claims

View the original article h...

Read More

Have Machinery Breakdown Insurance To Avoid Any Unseen Loses

View the original article h...

Read More

Pharma Is Doing All The Pulling For Johnson & Johnson

While other healthcare companies including Covidien (NYSE:COV) and Abbott (NYSE:ABT) have seen fit to split their drug and device businesses, it's perhaps lucky for Johnson & Johnson (NYSE:JNJ) shareholders that their company has not gone the same route. While it wasn't really so long ago that JNJ's drug business was struggling, now it's the consumer and device business that need the pick-me-up. Even with the strength of the drug business and...

Read More

Dover May Be Bottoming, But The Street's Already Thinking Recovery

Dover (NYSE:DOV) is one of those industrial conglomerates that is so diversified, it's not hard to feel a little sympathy for the analysts that cover the stock. From energy to smartphones to commercial refrigerators and gas pumps, covers the gamut of end-market exposures. To that end, it doesn't say anything especially great about the economy that first quarter results were pretty weak, though the book-to-bill and management's optimism about a second-half...

Read More

Mediocre Performance Clouding BB&T's Long-Term Value

The management of BB&T (NYSE:BBT) once enjoyed a pretty sterling reputation for their performance, but a variety of missteps seem to be accumulating. Couple that with “industry standard” mediocre performance, and I can understand why BB&T shares have gone almost nowhere over the past year and are, in fact, one of the worst performers of the peer group. For investors willing to play the long game, though, I do believe that meaningful value...

Read More

Intel – A Bond's Downside And A Stock's Upside?

Intel (Nasdaq:INTC) still has a long road ahead of it to regain the love of tech investors who believe that the core PC market is in permanent decline and that rivals like Qualcomm (Nasdaq:QCOM) and ARM Holdings (Nasdaq:ARMH) are still too far ahead in the expanding mobile market. The concerns about Intel – revenue growth potential, cost structure, capital spending needs – are valid, but should also be viewed in context. Even though Intel is currently...

Read More

Is Pepsi's Turnaround For Real?

Pepsico (NYSE:PEP) announced first quarter earnings April 18. Better than expected, its stock jumped more than 3% on the news. The soda pop and snack food conglomerate is in the midst of a revitalization that's getting a lot of attention from investors. With its stock up 20% year-to-date, I question whether its good performance will continue. Read on and I'll look at the pros and cons of Pepsi's latest results.Earnings - The GoodPepsico originally...

Read More

Joh. A Benckiser Looks To Corner The Coffee Market

D.E. Master Blenders 1753 (OTC:DEMBF), the former Sara Lee spinoff is going private after less than a year. Joh. A Benckiser Sarl (JAB) is paying a huge price for the European coffee maker. What does this mean for the rest of the world's coffee manufacturers? Is Green Mountain next? I'll have a look at some of the ways investors can make money from Benckiser's move to corner the coffee market. Bart BechtThat name probably doesn't ring a bell, but...

Read More

Investors Seem To Be Overrating Bank Of America

Few large bank stocks have come close to the market performance of Bank of America (NYSE:BAC) over the past year. While some of that appreciation may have been due to investors accepting that BoA is still a going concern in banking, the reality is that the bank still has a lot of work left to do, and the current banking environment is not exactly hospitable. With legal risks still pretty high and near-term growth opportunities looking more modest,...

Read More

Does A Tough Patch Really Matter To McDonald's Shareholders?

Excellent earnings consistency and a long history of dividend payments will buy a lot of patience and support from investors. Consequently, I find it hard to imagine that even this disappointing patch of weak same-store sales will really dent McDonald's (NYSE:MCD) all that much. Though I'm not very fond of the multiples being paid for consumer stocks these days and won't be looking to add McDonald's to my own portfolio, I don't expect a mass exodus...

Read More

Is Controversy About Robot-Assisted Surgery Showing In Intuitive Surgical's Numbers?

There has always been controversy around Intuitive Surgical (Nasdaq:ISRG) and its daVinci robotic surgical system. In recent months this controversy has reignited over allegations that device malfunctions/adverse events are increasing and that the system is little more than an expensive, unnecessary toy in procedures like minimally invasive hysterectomy. Making matters worse, this has long been an expensive stock where success has been predicated...

Read More

Three Ways To Short Gold

Gold’s recent sell-off has been nothing less than spectacular. Over the last week or so, prices for the precious metal have plunged nearly 12%, and touched lows not seen in the last two years. This certainly has stung many gold-bug portfolios, and it definitely came as a surprise. Since 2001, gold prices have surged more than 600% as sovereign bond risk and rock-bottom interest rates have taken hold. However, the recent improving financial landscape...

Read More

Weak PC Growth And Slow Mobile Penetration Weighing On Microsoft

It really is too bad that the conversation on Microsoft (Nasdaq:MSFT) always seems to be dominated by what the company isn't. Bearish analysts and investors hammer the company for its heavy reliance on PCs and fault the company for letting Apple (Nasdaq:AAPL) and Google (Nasdaq:GOOG) build such a large lead in mobile operating systems, while also complaining about the company's relatively weak online business and below-average entertainment profitability.Those...

Read More

Stick With “Bond-Like Stocks”

With the recent rout in various commodities and global growth concerns now creeping back into the headlines, investors are understandably getting nervous. After all, it was only a few years ago that the Great Recession took hold. With that in mind, U.S. Treasuries have once again become the asset class du jour as investors flocked to funds like the iShares Barclays 7-10 Year Treasury ETF (NYSE:IEF). However, with yields on fixed income investments...

Read More

Fairway Group Gets The Green

Grocery store chain Fairway Group (Nasdaq:FWM) sold 16.7 million shares at $13 in its IPO debut April 16. In its first day of trading shares gained 33.5%. Year-to-date it's the second best performing IPO next to ExOne (Nasdaq:XONE), which gained 47.3% in its coming out party. The question for those who weren't able to pick up shares at $13 is whether you should still be buying north of $17. Read on and I'll give you an answer. Discount Brokers Comparison:...

Read More

CSX Adapting To New Realities

It wasn't long ago at all that the rails seemed to have things pretty much all going their way. Better management was producing better margins, pricing advantages over trucking were leading to good intermodal growth, and a recovering economy was supporting higher traffic and strong pricing. Then came a structural shift in electricity generation and a serious drought that hammered both coal and agricultural volumes. To its credit, eastern rail operator...

Read More

Broad Weakness Makes It Harder To Like St. Jude Today

I've been relatively optimistic about St. Jude Medical's (NYSE:STJ) long-term prospects as the company navigates its current multi-year lull in growth. The company has a legitimate presence in important markets like cardiac rhythm management, atrial fibrillation, neurostimulation, and heart valve replacement, plus a pipeline that could reignite growth. With all of that said, it's still getting harder to ignore the realities of just how growth-challenged...

Read More

The “Healthy” Play In Contract Research Organizations

Big pharmaceutical companies like Merck (NYSE:MRK) are facing a major hurdle- it takes a lot of work and money in order to get a new drug to market. From beginning research to running clinical trials, creating new therapies is a daunting task. That task becomes even more daunting as robust cash flows from blockbuster drugs begin to dry up as they go off patent. In order to save on expenses and costs, biotech and drug manufacturers have started outsourcing...

Read More

Nokia Still Straddling Fault Lines

Nokia Still Straddling Fault Linesby Stephen D. Simpson, CFA Roughly 18 months into his tenure as the CEO of Nokia (NYSE:NOK), Stephen Elop hasn't yet proven much of anything about the future of this former mobile device leader. The company has done a better-than-expected job of cutting costs and its Nokia Siemens Networks joint venture is looking a lot better, but the company continues to lose mobile device share at an alarming rate. While the...

Read More

IBM Makes It Official – Tech Has Some Troubles

Although I doubt there were many investors still holding serious hope that the first quarter of 2013 was going to end up being a good one for tech companies, IBM (NYSE:IBM) likely snuffed out those hopes with an uncommonly weak quarter. With Big Blue missing for the first time in eight years, and missing across the board, it's pretty clear that business conditions have slowed markedly. Management remains optimistic that business will recover with...

Read More

GE's Guidance Wasn't Great, But Expectations Seem Low

Many investors are desperately hanging on to the idea that the economy will spring back in the second half and validate the multiples in the market. When companies like General Electric (NYSE:GE) report earnings and give guidance that makes that second-half recovery look shakier, the stocks pay the price. While I understand short-term investors selling GE on disappointment over the company's outlook, the stock still seems too cheap from a long-term...

Read More